Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
作者信息
Cui Xiaoteng, Wang Qixue, Kang Chunsheng
机构信息
Lab of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
出版信息
Front Immunol. 2021 Oct 27;12:788733. doi: 10.3389/fimmu.2021.788733. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?社论：免疫肿瘤学的最新进展，胶质母细胞瘤该何去何从？
Front Immunol. 2021 Oct 27;12:788733. doi: 10.3389/fimmu.2021.788733. eCollection 2021.
2
Immunotherapy for Glioblastoma: Current Progress and Challenges.胶质母细胞瘤的免疫治疗：现状与挑战。
Front Immunol. 2021 May 13;12:676301. doi: 10.3389/fimmu.2021.676301. eCollection 2021.
3
Current Immunotherapies for Glioblastoma Multiforme.目前用于多形性胶质母细胞瘤的免疫疗法。
Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020.
4
Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.嵌合抗原受体 T 细胞疗法治疗多形性胶质母细胞瘤的研究进展。
Cancer Med. 2021 Aug;10(15):5019-5030. doi: 10.1002/cam4.4064. Epub 2021 Jun 19.
5
Crosstalk Between Tumor-Associated Microglia/Macrophages and CD8-Positive T Cells Plays a Key Role in Glioblastoma.肿瘤相关小胶质细胞/巨噬细胞与 CD8 阳性 T 细胞的串扰在胶质母细胞瘤中起关键作用。
Front Immunol. 2021 Jul 29;12:650105. doi: 10.3389/fimmu.2021.650105. eCollection 2021.
6
Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies.当前胶质母细胞瘤靶向治疗的挑战：聚焦免疫治疗策略。
Int J Mol Sci. 2021 Mar 28;22(7):3493. doi: 10.3390/ijms22073493.
7
Glioblastoma Therapy in the Age of Molecular Medicine.分子医学时代的胶质母细胞瘤治疗
Trends Cancer. 2019 Jan;5(1):46-65. doi: 10.1016/j.trecan.2018.11.002. Epub 2018 Dec 7.
8
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients.免疫疗法促使胶质母细胞瘤患者的间充质肿瘤细胞状态转变和 TME 免疫反应。
Neuro Oncol. 2024 Aug 5;26(8):1453-1466. doi: 10.1093/neuonc/noae085.
9
Editorial (Thematic Issue: Clinical Advances in Immuno-oncology - Progress Towards Selective Cure).社论（专题：免疫肿瘤学的临床进展——迈向选择性治愈的进程）
Curr Mol Pharmacol. 2016;9(3):182. doi: 10.2174/1874467208999150716103938.
10
Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma.武装杀伤性T细胞：洞悉过继性T细胞转移在胶质母细胞瘤中的作用
Immunotherapy. 2015;7(5):481-5. doi: 10.2217/imt.15.22.
Zotero 插件